Understanding factors affecting treatment for pectus carinatum using a compression system
Prognosis Factors for the Treatment of Pectus Carinatum With a Dynamic Compression System
This study looks at how different factors like age and gender affect the success of a chest compression treatment for people with pectus carinatum.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 520 (estimated) |
| Ages | 6 Years to 40 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 1 site (Saint-Etienne) |
| Trial ID | NCT04452721 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the prognosis factors that influence the success of treating pectus carinatum with a dynamic compression system. Patients wear a harness that applies moderate pressure to remodel the chest over an average duration of one year. The study aims to identify key parameters, such as age, gender, and initial correction pressure, that may predict treatment outcomes. The local cohort is one of the largest globally, providing a robust dataset for analysis.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with pectus carinatum who have undergone treatment at Saint-Etienne University Hospital.
Not a fit: Patients who have not received treatment with the dynamic compression system or those with less than six months of follow-up may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance treatment strategies for pectus carinatum, leading to improved patient outcomes.
How similar studies have performed: Previous publications have shown the validity of the dynamic compression system, but this study aims to identify specific prognosis factors, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient who received proper information about the study. * Patient with clinically diagnosed pectus carinatum. * Treated at Saint-Etienne University Hospital using a dynamic compression system. * Between October 2011 and January 2020 for the retrospective part, then between January 2020 and January 2022 for the validation cohort. * With more than 6 months of follow-up since the beginning of the treatment. Exclusion Criteria: \-
Where this trial is running
Saint-Etienne
- CHU de Saint-Etienne — Saint-Etienne, France (Recruiting)
Study contacts
- Principal investigator: Aurélien SCALABRE — Centre Hospitalier Universitaire de Saint Etienne
- Study coordinator: Aurélien SCALABRE
- Email: aurelien.scalabre@chu-etienne.fr
- Phone: 04 77 82 94 49
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.